Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intestinal
ornithine decarboxylase
[
L-ornithine carboxy-lyase
, EC 4.1.1.17] activity was found to show a marked circadian rhythm with a peak 4 h after the start of eating in rats on a diet containing protein. In rats with an intestinal blind loop, the enzyme was induced in the portion of the intestine that came in contact with the protein meal, but not in the blind loop. Injection of tetragastrin or CCK-PZ alone had no effect on enzyme induction, but when a protein suspension was introduced into a tied loop of intestine soon after the injection of tetragastrin or CCK-PZ, the enzyme was induced in the segment to almost the same extent as in the intestines of normal rats eating a protein meal. These results suggest that the circadian rhythm in activity of intestinal
ornithine decarboxylase
is initiated by release of
gastrin
, or CCK-PZ, or both, and contact of protein with the small intestine after the intake of food containing protein.
...
PMID:Circadian rhythm in the ornithine decarboxylase activity of rat small intestine. 62 5
The polyamines spermidine and spermine are essential for cell proliferation. Most growth factors stimulate polyamine synthesis by inducing
ornithine decarboxylase
activity, which catalyzes the formation of putrescine from ornithine. Putrescine can then be utilized either for polyamine biosynthesis or may serve as a substrate for diamine oxidase (DAO), leading to formation of gamma-aminobutyric acid (GABA). Growth of the oxyntic mucosa of the stomach is stimulated by feeding, by trophic hormones such as
gastrin
and by exogenous administration of putrescine. Conversely, fasting, as well as
ornithine decarboxylase
inhibition decrease oxyntic mucosal DNA synthesis. We now demonstrate that fasted rats show a high degree of [3H]GABA formation from [3H]putrescine in the oxyntic mucosa and that feeding or injections of
gastrin
, caerulein or the DAO-inhibitor aminoguanidine decrease such [3H]GABA formation and, instead, stimulate formation of [3H]spermidine. Moreover,
gastrin
injections reduced oxyntic mucosal DAO activity. Thus, oxyntic mucosal DAO activity is regulated by tropic factors and may be involved in growth regulation by controlling intramucosal putrescine metabolism.
...
PMID:Regulation of gastric mucosal diamine oxidase activity by gastrin. 164 66
Polyamines are essential factors of cell growth and differentiation. Modulation of the cellular polyamine content by 2-difluoromethylornithine (DFMO) inhibiting
ornithine decarboxylase
(
ODC
), or by hormones inducing
ODC
, influences cell growth.
Gastrin
acts trophically on some colonic carcinomas and their growth is inhibited by gastrin receptor blockers. The mechanism of the trophic action of
gastrin
on colonic carcinomas is not known. In this study the effect of
gastrin
, gastrin receptor blockers, epidermal growth factor (EGF) and DFMO on growth and
ODC
activity of four human colon carcinoma cell lines (SW 403, SW 1116, LS 174 T and Lovo) was investigated. Growth and
ODC
activity of all cell lines were inhibited by DFMO. Growth of the SW 403 cell line was increased by
gastrin
and inhibited by the gastrin receptor blocker benzotrypte. The other cell lines did not respond to
gastrin
and the gastrin receptor blocker. In SW 403 cells
ODC
activity was increased by
gastrin
, and was also elevated after treatment with the gastrin receptor blocker. These in vitro results were confirmed by studies on tumours that developed from SW 403 cells in nude mice. Combination of benzotrypte and DFMO did not enhance the antiproliferative effect. EGF increased growth of SW 403 cells, but no induction of
ODC
activity was measured. LS 174 T cells were not stimulated by EGF. Medium replacement was the strongest stimulus of
ODC
activity in SW 403 cells already inducing
ODC
after 3 h. During cell culture
ODC
activity was high after seeding and decreased continuously with increasing cell density. These data suggest that
gastrin
induces
ODC
in
gastrin
-sensitive colonic carcinoma cells. DFMO appears to be a valuable antiproliferative agent in colonic carcinoma cells.
...
PMID:Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells. 199 67
Since accelerated turnover of histamine in oxyntic mucosa may be an important factor in the pathogenesis of peptic ulcers, the effect of dexamethasone and other glucocorticoids on the activity of gastric histidine decarboxylase (HDC) was studied in the rat. The activity of HDC in rat oxyntic mucosa increased significantly after dexamethasone was injected s.c. to rats at doses larger than 0.4 mg/kg body weight. The maximum response of the HDC activity to dexamethasone (4 mg/kg) was observed 8 h after the treatment. The activity of
ornithine decarboxylase
(
ODC
) increased at 4 h, while that of DOPA decarboxylase showed no significant change throughout the 16-h period following a single injection of dexamethasone. The mucosal levels of histamine, putrescine, and spermidine rose significantly after the steroid treatment, while the spermine levels remained nearly constant. There was no sex difference in these responses to dexamethasone. Betamethasone showed nearly the same effects as dexamethasone on the decarboxylase activities and the mucosal levels of diamines. Serum
gastrin
levels showed no significant change for the first 4 h and then rose significantly 8 and 16 h after dexamethasone treatment. Pentagastrin (0.5 mg/kg) increased the HDC activity, while it showed no significant effect on either the mucosal
ODC
activity or levels of polyamines and histamine. These data suggest that dexamethasone influences the metabolism of histamine and polyamines in rat oxyntic mucosa both directly and via stimulation of
gastrin
release.
...
PMID:Effects of dexamethasone on the activity of histidine decarboxylase, ornithine decarboxylase, and dopa decarboxylase in rat oxyntic mucosa. 203 98
Gastrin
has two principal biological effects: stimulation of acid secretion from gastric parietal cells and stimulation of mucosal growth in the acid-secreting part of the stomach. Circulating
gastrin
regulates the increase in acid secretion that occurs during the after meals.
Gastrin
also stimulates mucosal growth in the stomach. Exogenously administered
gastrin
causes increased cell division in the proliferative zone that lies between the surface cells and the gastric glands in the acid-secreting mucosa. The newly formed cells undergo differentiation into surface epithelial cells, parietal cells and gastric enterochromaffin-like cells. Furthermore, the increased mucosal proliferation that occurs with refeeding after a period of fasting may be mediated by
gastrin
since refeeding stimulates
gastrin
production and a parallel increase in mucosal DNA synthesis. Both food and
gastrin
cause a rapid increase in cell division and an increase in gastric
ornithine decarboxylase
mRNA in fasting rats. In preliminary immunoneutralization experiments, the stimulation of
ornithine decarboxylase
produced by food was inhibited by
gastrin
antibody. The sustained inhibition of gastric acid secretion obtained by surgery or with antisecretory drug therapy results in hypergastrinaemia associated with increased gastric mucosal cell proliferation. A good correlation between gastric enterochromaffin-like cell density and circulating
gastrin
concentrations has been found under these conditions as well as during infusions of exogenous
gastrin
. Trophic effects of
gastrin
have also been reported for the colon, duodenum and pancreas, but chronic hypergastrinaemia does not appear to produce hyperplasia of these organs.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Role of gastrin as a trophic hormone. 209 9
An organ culture system was utilized to evaluate the role of tyrosine kinases (Tyr-k) and tyrosine-specific phosphorylation of proteins in
gastrin
regulation of
ornithine decarboxylase
(
ODC
) activity in colonic mucosa. Exposure of colonic mucosal explants to
gastrin
(50-100 ng G-17 I/ml) resulted in a profound stimulation of both Tyr-k and
ODC
activities compared with the corresponding basal levels. Whereas the maximal stimulation (ranging between 70 and 150%) of Tyr-k occurred within 10-15 min of exposure to
gastrin
,
ODC
activity was significantly stimulated (180%) 2 h after exposure to the hormone, and at 4 h it was found to be 750% above the corresponding basal level. Difluoromethylornithine (DFMO; 2 mM), an irreversible inhibitor of
ODC
, completely abolished the
gastrin
-mediated stimulation of
ODC
but not Tyr-k activity. On the other hand, genistein (100 micrograms/ml), a specific inhibitor of Tyr-k, caused a total suppression of the
gastrin
-induced stimulation of both Tyr-k and
ODC
.
Gastrin
also stimulated tyrosyl phosphorylation of a colonic mucosal membrane protein with molecular mass of 57 kDa, and genistein greatly attenuated this effect. We conclude that
gastrin
stimulates colonic mucosal
ODC
in vitro, and Tyr-k may be required for the regulation of this process.
...
PMID:Role of tyrosine kinases in gastrin induction of ornithine decarboxylase in colonic mucosa. 222 Oct 73
Recent studies have demonstrated the presence of both CCKA and CCKB receptors on dog and guinea pig pancreas. Although CCKA receptors are implicated in enzymatic secretion, biological effects of CCKB receptors are still unknown. We have previously found that a rat acinar pancreatic cell line (AR4-2J) possesses both receptor subtypes. In this work we report the ability of various CCK/
gastrin
agonists and antagonists to bind with these receptors. We found that
gastrin
, pentagastrin and
Gastrin
/CCK4 induce
ornithine decarboxylase
activity, an early event involved in cell proliferation, as well as 3H-thymidine incorporation. Furthermore, these effects occur at doses at which these peptides interact only with the CCKB receptor subtype. In view of these data we propose that modulation of AR4-2J cell growth by
gastrin
agonists specifically involve occupation of the CCKB receptor.
...
PMID:Gastrin modulates growth of a rat acinar pancreatic cell line: receptor analysis and signal transduction. 226 50
An organ culture system was utilized to examine the effect of
gastrin
(G-17-I) and epidermal growth factor (EGF) on colonic mucosal
ornithine decarboxylase
(
ODC
) activity, and the expression of the
ODC
gene. Exposure of colonic mucosal explants to either
gastrin
or EGF (50-500 ng/ml) for only 4 h resulted in a profound stimulation (150-600%) in
ODC
activity over the basal level. These increases were essentially abolished by difluoromethylornithine (DFMO; 2 nmol/ml) or CaCl2 (2 umol/ml).
Gastrin
also activated the
ODC
gene in the colonic mucosa as evidenced by increased steady-state
ODC
mRNA levels in the colonic mucosal explants after 4 h exposure to the hormone, when compared with the controls. It is concluded that colonic mucosal
ODC
is responsive to both
gastrin
and EGF.
...
PMID:Gastrin and epidermal growth factor induction of ornithine decarboxylase in rat colonic explants. 231 6
Many reports emphasized the role of
gastrin
as growth factor on normal gastrointestinal mucosa and pancreas. In the present study, we analyzed the proliferative effects of cholecystokinin (CCK) and
gastrin
peptides on a rat tumoral pancreatic cell line, AR42J, which possesses both CCKA and CCKB receptor subtypes. The results showed a good correlation between the binding of
gastrin
to CCKB receptor [Kd 1.125 +/- 0.3 (SD) nM] and its ability to either induce
ornithine decarboxylase
activity [50% effective concentration, 0.6 +/- 0.3 nM] and [3H]-thymidine incorporation [50% effective concentration, 2 +/- 0.4 nM]. Furthermore, the ability of different cholecystokinin and
gastrin
antagonists such as proglumide and asperlicin derivatives (respectively, CR1409, CR1505, and L364,718) were tested. We found that all antagonists displaced 125I-labeled
gastrin
binding, with the following order of potencies: L364,718 greater than CR1409 greater than CR1505 greater than proglumide. Furthermore, the 50% inhibitory concentration of CR1409 and CR1505 to inhibit
gastrin
stimulated
ornithine decarboxylase
activity (an early event involved in cell proliferation) and [3H]thymidine incorporation were in agreement with their constants of inhibition (Ki) on
gastrin
binding. The L364,718 compound, at a concentration which fully occupied the CCKA without affecting the CCKB, had no effect on
gastrin
stimulated
ornithine decarboxylase
activity and [3H]thymidine incorporation. In addition, this compound appeared to be a full agonist on CCKB receptor. These results confirm the implication of the CCKB receptor in the proliferative response of AR42J cells to
gastrin
.
...
PMID:Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J). 239 52
The mechanism by which the hormone
gastrin
induces growth of the gastrointestinal mucosa is unknown. Many hormones are inducers of
ornithine decarboxylase
(
ODC
), the rate-limiting enzyme in the synthesis of the polyamines putrescine, spermidine, and spermine. Although the exact biochemical function of the polyamines is not completely understood, they appear to be required for normal cell growth and differentiation. Rats were maintained on a liquid diet for 5 days and treated with difluoromethylornithine (DFMO, 200 mg/kg ip, 3 times/day), a selective, irreversible inhibitor of
ODC
, for 5 days. Half of these animals also received pentagastrin (250 mg/kg ip) during the final 3 days of the treatment schedule. DFMO alone had no effect on body weight or mucosal growth. Pentagastrin increased total RNA, DNA, and protein in the oxyntic gland and duodenal and colonic mucosa. Concurrent treatment with DFMO completely inhibited the trophic response to pentagastrin in the oxyntic gland area of the stomach and the duodenal mucosa. In contrast, DFMO was without effect on response of the colonic mucosa to pentagastrin. Pentagastrin treatment did not induce the mucosal
ODC
activity of the oxyntic gland area of the stomach, the duodenum, the ileum, or the proximal colon of either animals fasted for 48 h or animals maintained on a liquid diet.
ODC
activity was measured at 4, 8, 12, and 24 h after administration of hormone. These results suggest that, in at least the proximal bowel, the stimulation by
gastrin
of nucleic acid and protein synthesis requires intact polyamine synthesis but that
gastrin
itself does not induce
ODC
.
...
PMID:Attenuation of trophic response to gastrin after inhibition of ornithine decarboxylase. 240 17
1
2
3
4
Next >>